Skip to main content
SpringerLink
Log in

Malignant Melanoma

  • Chapter
  • First Online:
Uncommon Ulcers of the Extremities

  • 127 Accesses

Abstract

A lower extremity ulcer is full thickness skin loss with progression into chronic wound, which shows no tendency to heal after 3 months of appropriate treatment or is still not fully healed at 12 months [1]. Chronic wounds may be of malignant etiology and as high as 10.4% incidence has been reported [2]. Malignant melanoma is a malignancy of aggressive behavior that develops when melanin-producing melanocytes originating from the neural crest undergo malignant transformation. Melanoma can develop in other places where neural crest cells migrate, such as the gastrointestinal system and the brain, and is most commonly found on the skin [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kahle B, Hermanns HJ, Gallenkemper G. Evidence-based treatment of chronic leg ulcers. Dtsch Arztebl Int. 2011;108(14):231–7. https://doi.org/10.3238/arztebl.2011.0231.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Senet P, Combemale P, Debure C, Baudot N, Machet L, Aout M, Lok C. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective multicentre, cross-sectional study. Arch Dermatol. 2012;148:704–8.

    Article  PubMed  Google Scholar 

  3. Heistein JB, Acharya U. Malignant melanoma. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2021.

    Google Scholar 

  4. American Cancer Society. Cancer facts & figures 2021. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed 20 Mar 2022.

  5. Donley GM, Liu WT, Pfeiffer RM, McDonald EC, Peters KO, Tucker MA, Cahoon EK. Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States. Br J Cancer. 2019;120(7):754–60.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dalvin LA, Damento GM, Yawn BP, Abbott BA, Hodge DO, Pulido JS. Parkinson disease and melanoma: confirming and reexamining an association. Mayo Clin Proc. 2017;92(7):1070–9.

    Article  PubMed  Google Scholar 

  7. Amber TL, Bruce HL. The Washington manual of surgery. 6th ed. St Luis: Wolters-Kluwer-Lippincott Williams and Wilkins; 2012.

    Google Scholar 

  8. Kantor J, Kantor DE. Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol. 2009;145(8):873–6.

    Article  PubMed  Google Scholar 

  9. Sabel MS, Wong SL. Review of evidence-based support for pretreatment imaging in melanoma. J Natl Compr Cancer Netw. 2009;7(3):281–9.

    Article  Google Scholar 

  10. Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103(2):129–42.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Farah M, Chung HJ. Diagnostic utility of preferentially expressed antigen in melanoma immunohistochemistry in the evaluation of melanomas with a co-existent nevoid melanocytic population: a single-center retrospective cohort study. J Am Acad Dermatol. 2021;87:486.

    Article  PubMed  Google Scholar 

  12. Cesinaro AM, Piana S, Paganelli A, Pedroni G, Santandrea G, Maiorana A. PRAME expression in cellular neurothekeoma: a study of 11 cases. J Cutan Pathol. 2021;49:338.

    Article  PubMed  Google Scholar 

  13. Hu J, Cai X, Lv JJ, Wan XC, Zeng XY, Feng ML, et al. PRAME immunohistochemistry as an adjunct for differential diagnosis in acral lentiginous melanoma and acral nevi. Hum Pathol. 2021;120:9.

    Article  PubMed  Google Scholar 

  14. Rashid S, Tsao H. Recognition, staging, and management of melanoma. Med Clin North Am. 2021;105(4):643–61.

    Article  PubMed  Google Scholar 

  15. Wilson ML. Histopathologic and molecular diagnosis of melanoma. Clin Plast Surg. 2021;48(4):587–98.

    Article  PubMed  Google Scholar 

  16. Revythis A, Shah S, Kutka M, Moschetta M, Ozturk MA, Pappas-Gogos G, et al. Unraveling the wide spectrum of melanoma biomarkers. Diagnostics (Basel). 2021;11(8).

    Google Scholar 

  17. Bronstein Y, Ng CS, Rohren E, Ross MI, Lee JE, Cormier J, et al. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012;198(4):902–8.

    Article  PubMed  Google Scholar 

  18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: melanoma: cutaneous. NCCN. http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf. Version 1.2022–3 Dec 2021; Accessed 6 Dec 2021.

  19. Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet. 2011;378(9803):1635–42.

    Article  PubMed  Google Scholar 

  20. Melanoma Treatment (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq#link/_25_toc. 2021. Accessed 25 Apr 2022.

  21. Bachter D, Michl C, Buchels H, Vogt H, Balda BR. The predictive value of the sentinel lymph node in malignant melanomas. Recent Results Cancer Res. 2001;158:129–36.

    Article  CAS  PubMed  Google Scholar 

  22. American Joint Committee on Cancer. Melanoma of the skin. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, et al., editors. AJCC staging manual. 8th ed. New York: Springer; 2016.

    Google Scholar 

  23. Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208–50.

    Article  PubMed  Google Scholar 

  24. Michielin O, van Akkooi A, Lorigan P, et al. ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO guidelines committee. Ann Oncol. 2020;31:1449.

    Article  CAS  PubMed  Google Scholar 

  25. Garbe C, et al. European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based inter-disciplinary guideline for melanoma. Part 1: diagnostics—update 2019. Eur J Cancer. 2020;126:141–58.

    Article  CAS  PubMed  Google Scholar 

  26. Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol. 2011;65:1032.

    Article  PubMed  Google Scholar 

  27. Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–22.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66(3):438–44.

    Article  PubMed  Google Scholar 

  29. Saberian C, Sperduto P, Davies MA. Targeted therapy strategies for melanoma brain metastasis. Neurooncol Adv. 2021;3(Suppl 5):v75–85.

    PubMed  PubMed Central  Google Scholar 

  30. Khaddour K, Maahs L, Avila-Rodriguez AM, Maamar Y, Samaan S, Ansstas G. Melanoma targeted therapies beyond BRAF-mutant melanoma: potential druggable mutations and novel treatment approaches. Cancers (Basel). 2021;13(22).

    Google Scholar 

  31. Zeng H, Liu F, Zhou H, Zeng C. Individualized treatment strategy for cutaneous melanoma: where are we now and where are we going? Front Oncol. 2021;11:775100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Teixido C, Castillo P, Martinez-Vila C, Arance A, Alos L. Molecular markers and targets in melanoma. Cell. 2021;10(9).

    Google Scholar 

  33. Ferrucci PF, Lens M, Cocorocchio E. Combined BRAF-targeted therapy with immunotherapy in BRAF-mutated advanced melanoma patients. Curr Oncol Rep. 2021;23(12):138.

    Article  CAS  PubMed  Google Scholar 

  34. Murali R, Desilva C, Thompson JF, Scolyer RA. Factors predicting recurrence and survival in sentinel lymph node-positive melanoma patients. Ann Surg. 2011;253(6):1155–64.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

    Satyendra Kumar Tiwary

Authors
  1. Satyendra Kumar Tiwary
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Medical Sciences, Department of Surgery, Banaras Hindu University, Varanasi, India

    Ajay K. Khanna

  2. Institute of Medical Sciences, Department of General Surgery, Banaras Hindu University, Varanasi, India

    Satyendra Kumar Tiwary

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tiwary, S.K. (2023). Malignant Melanoma. In: Khanna, A.K., Tiwary, S.K. (eds) Uncommon Ulcers of the Extremities. Springer, Singapore. https://doi.org/10.1007/978-981-99-1782-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1782-2_23

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1781-5

  • Online ISBN: 978-981-99-1782-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation